Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jeannine M Fisher"'
Autor:
Gerald R. Galluppi, Daniel G. Polhamus, Jeannine M. Fisher, Seth C. Hopkins, Kenneth S. Koblan
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1245-1254 (2021)
Abstract Ulotaront (SEP‐363856) is a trace amine–associated receptor 1 agonist with 5‐HT1A agonist activity in phase III development for the treatment of schizophrenia. The efficacy of ulotaront is not mediated by blockade of D2 or 5‐HT2A rec
Externí odkaz:
https://doaj.org/article/f693281ae3224c6683dcfce7c9046cff
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1245-1254 (2021)
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1245-1254 (2021)
Ulotaront (SEP‐363856) is a trace amine–associated receptor 1 agonist with 5‐HT1A agonist activity in phase III development for the treatment of schizophrenia. The efficacy of ulotaront is not mediated by blockade of D2 or 5‐HT2A receptors. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b75b0f1e58b64c2d6827ddd3b209f1d4
https://pubmed.ncbi.nlm.nih.gov/34292664
https://pubmed.ncbi.nlm.nih.gov/34292664
Autor:
Amarnath Sharma, Lisa J. Benincosa, Rebecca J. Benner, Robert R. LaBadie, Ping Liu, Jeannine M Fisher, Charles Xie, Jeanne D. Breen, Ridia Chandra
Publikováno v:
Clinical Pharmacokinetics. 46:247-259
A novel oral, extended-release, microsphere formulation of azithromycin (AZSR) was developed to improve the gastrointestinal tolerability profile while allowing administration of an entire treatment course of azithromycin in a single dose. Several ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d8c62be67806044bcb7189da87913b
https://doi.org/10.2165/00003088-200746030-00005
https://doi.org/10.2165/00003088-200746030-00005
Autor:
Jacob V. Aranda, Gabriela M. Espinoza, Charles Knirsch, Gregory L. Kearns, Jeannine M. Fisher, Richa Chandra, Richard F. Jacobs, Holly D. Maples
Publikováno v:
Pediatric Infectious Disease Journal. 24:34-39
The objective of this study was to characterize the pharmacokinetics and tolerance of a single intravenous (IV) azithromycin dose in children.Subjects were stratified into 4 age groups: 0.5-2 years;2-6 years; 6-12 years; and 12-16 years. Each subject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abea65ffab795168dd1d9355d1b6366a
https://doi.org/10.1097/01.inf.0000148927.48680.fc
https://doi.org/10.1097/01.inf.0000148927.48680.fc
Autor:
Kenneth E. Thummel, E. Patchen Dellinger, Evan D. Kharasch, Jeannine M. Fisher, Kris V. Kowdley, Jenny Y. Chien, Maurice G. Emery
Publikováno v:
Hepatology. 38:428-435
Previous studies suggest that hepatic cytochrome P450 2E1 (CYP2E1) activity is increased in individuals with chronic alcoholism, nonalcoholic steatohepatitis (NASH), and morbid obesity, and may contribute to liver disease. We studied 16 morbidly obes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1824afaa8e343d8650dea181e84dc2a
https://doi.org/10.1053/jhep.2003.50342
https://doi.org/10.1053/jhep.2003.50342
Autor:
Robert Moller, Sheela Kolluri, Robert L. Walsky, M. J. Gardner, R. Scott Obach, Jeannine M Fisher, Ann Taylor
Publikováno v:
The Annals of pharmacotherapy. 40(1)
Background: Lasofoxifene, a selective estrogen receptor modulator, may be coadministered with other drugs, raising the issue of drug–drug interactions. Objective: Using a 7-day, open-label, sequential study to determine whether lasofoxifene at stea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c2ca3e22fe133f24f4954ae730cefb
https://pubmed.ncbi.nlm.nih.gov/16368922
https://pubmed.ncbi.nlm.nih.gov/16368922
Autor:
Mary F. Paine, Kenneth E. Thummel, Phyllissa Schmiedlin-Ren, Paul B. Watkins, Jeannine M. Fisher, Kenneth S. Lown
Publikováno v:
Molecular pharmacology. 51(5)
The human colon carcinoma cell line, Caco-2, is widely used as a model for oral absorption of xenobiotics. The usefulness of Caco-2 cells has been limited, however, because they do not express appreciable quantities of CYP3A4, the principle cytochrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a52d32714e2c47bdf03ea305ee38ca9
https://pubmed.ncbi.nlm.nih.gov/9145912
https://pubmed.ncbi.nlm.nih.gov/9145912
Autor:
Robert J. Fountaine, David Albert Fryburg, Jeannine M. Fisher, Robert R. Henry, Susan A. Willavize
Publikováno v:
Endocrine Practice. 11:28-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c84a0cc9c54cff2ef9dc46935a8e485
https://doi.org/10.1016/s1530-891x(20)43705-x
https://doi.org/10.1016/s1530-891x(20)43705-x
Autor:
Jeannine M. Fisher, Korbtham Sathirakul, EngSeng Seah, PaulR. Aftring, Moriyoshi Yasuda, StephanD. Wise
Publikováno v:
Diabetes Research and Clinical Practice. 50:109-110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e00cdd108f3bb4b6240dba66c6431c7
https://doi.org/10.1016/s0168-8227(00)81830-6
https://doi.org/10.1016/s0168-8227(00)81830-6